Lv5
1330 积分 2020-05-26 加入
Activation-optimized anti-CD3 valency control enables combinatorial discovery of multispecific nanoantibodies for solid tumor immunotherapy
18小时前
已完结
Activation-optimized anti-CD3 valency control enables combinatorial discovery of multi-specific nanoantibodies for solid tumor immunotherapy
19小时前
已完结
Activation-optimized anti-CD3 valency control enables combinatorial discovery of multi-specific nanoantibodies for solid tumor immunotherapy
20小时前
已关闭
基于检验数据的机器学习临床模型开发与应用专家共识(2026版)
22小时前
已完结
Clinical strategies with antibody–drug conjugates as potential modifications for virotherapy
7天前
已关闭
Clinical strategies with antibody–drug conjugates as potential modifications for virotherapy
7天前
已完结
Beyond cold to hot: oncolytic virotherapy as the next cornerstone of immuno-oncology
7天前
已完结
Development of Oncolytic Virus-Proteolysis-Targeting Chimera Conjugates for Tumor Immunotherapy
14天前
已完结
A high-MAPK, low-WNT cell state drives metastatic dissemination in colorectal cancer
28天前
已完结
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma
28天前
已完结